Overexpression of MYCN in SHEP, an NB cell line with no endogenous MYCN expression, resulted in a significant upregulation in KAT2A mRNA levels (Fig. 2C) detected by interrogating our previously published RNA-seq data (GSE208424) [11] and protein levels (Fig. 2D). The gene discussed is KAT2A; the disease is neuroblastoma.